BIRMINGHAM, AL, June 22, 2026 /24-7PressRelease/ — Birmingham OB/Gyn, in partnership with Onsite Women’s Health, is proud to announce the launch of Mammo with Heart, an innovative screening program that uses artificial intelligence to identify breast arterial calcifications (BAC) during routine mammography. The program provides women and their healthcare providers with additional insight into cardiovascular risk without added imaging, radiation, or appointments.
Heart disease remains the leading cause of death among women across Central Alabama, including Jefferson, Shelby, Blount, St. Clair, Walker, and Tuscaloosa Counties. According to the Alabama Public Health Community Health Profiles 2023, heart disease is the leading cause of death among women in Jefferson, Shelby, Blount, St. Clair, Walker, and Tuscaloosa Counties, as well as statewide. Female heart disease mortality rates range from 152.0 deaths per 100,000 women in Tuscaloosa County to 503.4 deaths per 100,000 women in Walker County.
“Women trust their OB/Gyn for preventive care throughout their lives,” said Ashley Przybysz, M.D., Birmingham OB/Gyn. “This program allows us to provide even more value from a screening test women are already receiving. By identifying potential cardiovascular risk earlier, we can help patients have important conversations with their healthcare providers before serious cardiovascular disease develops.”
Mammo with Heart uses FDA-cleared CureMetrix® cmAngio® technology to analyze routine mammography images for the presence of breast arterial calcifications. Research has shown that BAC may be associated with increased cardiovascular risk and can serve as an opportunity for earlier risk assessment and prevention.
The screening allows a routine mammogram to provide information about both breast health and heart health from a single exam. Breast arterial calcifications are present in approximately 12% to 42.5% of screening mammograms, yet historically many of these findings have not been routinely reported.
As part of this initiative, Birmingham OB/Gyn is working to develop a coordinated cardiovascular care pathway with Alabama Cardiovascular Group (ACG), an affiliate of Grandview Health, to help ensure that women identified as having elevated cardiovascular risk have access to timely specialty evaluation and preventive care when appropriate.
“For many women, their OB/Gyn is the healthcare provider they see most consistently,” said David Carmichael, CEO of Birmingham OB/Gyn. “This program gives us an opportunity to identify cardiovascular risk earlier and connect patients with appropriate preventive care before heart disease develops.”
Birmingham OB/Gyn performs more than 8,400 screening mammograms annually and delivered babies for families residing in 28 Alabama counties during the past year.
Mammo with Heart is now available to patients undergoing screening mammography at Birmingham OB/Gyn.
For more information, visit https://www.birminghamobgyn.com or call 205-933-8334.
About Birmingham OB/Gyn
Birmingham OB/Gyn is one of Alabama’s leading women’s healthcare practices, providing comprehensive obstetrical, gynecologic, breast imaging, preventive health, hormone therapy, and specialty services to women throughout Central Alabama. With offices in Birmingham, Hoover, and Trussville, the practice cares for patients from across the region and delivered babies for families residing in 28 Alabama counties during the past year. Birmingham OB/Gyn is committed to advancing women’s health through innovation, prevention, and coordinated care across every stage of life.
About Onsite Women’s Health
In partnership with forward-thinking providers across the country, Onsite Women’s Health offers comprehensive in-office breast health and imaging services anchored by advanced 3D screening mammography and artificial intelligence technologies. Onsite is committed to improving access to breast imaging, increasing screening compliance, and supporting earlier detection for women nationwide.
—
For the original version of this press release, please visit 24-7PressRelease.com here
Legal Disclaimer: The content on this page is syndicated from independent third-party providers. Kyrion Media makes no warranties or representations regarding the accuracy, completeness, legality, or reliability of the information, including text, images, videos, or licenses. If you are affiliated with this content or have any complaints, copyright concerns, or requests for removal, please contact us at retract@kyrionmedia.com with the specific URL of the content in question. We will review and address valid requests promptly.
